Article info

Download PDFPDF
CASE REPORT
Comparing APLS and oranges: caution with the use of direct-acting oral anticoagulants (DOACs) instead of warfarin in the treatment of antiphospholipid syndrome (APLS)

Authors

  1. Correspondence to Dr Luke Blagdon Snell, luke.snell{at}nhs.net
View Full Text

Citation

Benger M, Vink J, Snell LB, et al
Comparing APLS and oranges: caution with the use of direct-acting oral anticoagulants (DOACs) instead of warfarin in the treatment of antiphospholipid syndrome (APLS)

Publication history

  • Accepted February 19, 2019
  • First published April 1, 2019.
Online issue publication 
April 01, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.